1. Home
  2. CRNT vs VYGR Comparison

CRNT vs VYGR Comparison

Compare CRNT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.31

Market Cap

189.7M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.15

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRNT
VYGR
Founded
1996
2013
Country
Israel
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
194.0M
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
CRNT
VYGR
Price
$2.31
$4.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$4.00
$17.00
AVG Volume (30 Days)
423.1K
497.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,135,000.00
Revenue This Year
$8.91
N/A
Revenue Next Year
$6.42
$71.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.82
$2.65
52 Week High
$2.84
$5.55

Technical Indicators

Market Signals
Indicator
CRNT
VYGR
Relative Strength Index (RSI) 52.06 60.10
Support Level $2.24 $3.73
Resistance Level $2.43 $4.44
Average True Range (ATR) 0.11 0.24
MACD -0.00 0.08
Stochastic Oscillator 79.66 81.19

Price Performance

Historical Comparison
CRNT
VYGR

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: